#obesity drugs
articles
Companies
Novo Nordisk's Wegovy Pill Heads to Germany as Shares Slip on Pipeline Setback
Oral Wegovy is coming to Germany, but a CagriSema trial setback and modest pill sales tempered Novo Nordisk's guidance r...
Health
ADA Review, Retatrutide Access and GLP-1 Generics Lead a Busy Diabetes Week
A busy week for diabetes and obesity drugs: ADA reviews a police incident, Lilly expands retatrutide access, Novo faces ...
Companies
Novo Nordisk Sues Eli Lilly Over ‘Unfair’ Comparison of Weight-Loss Drugs
The Danish drugmaker claims Eli Lilly’s advertising for Zepbound and Mounjaro used outdated Wegovy doses, misleading pat...